Secukinumab: The Anti-IL-17A Biologic for the Treatment of Psoriasis

Case Rep Dermatol. 2019 Sep 20;11(Suppl 1):1-3. doi: 10.1159/000501991. eCollection 2019 Sep-Dec.
No abstract available

Publication types

  • Editorial